A novel SARS-CoV-2 Point-of-Care Diagnostic Test Kit

CT-Scientific Viral Antigen Point-of-Care (POC) Detection Test to Detect the Status of Current Infection

Our viral antigen detection test has been developed at Harvard University to provide a novel POC diagnostic test using microfluidic based-technology to deliver rapid, user-friendly, simple, and accurate diagnostic results. We look forward to working with governments, health systems clinics, pharmacies, health care centers in Canada and US to address the COVID-19 crisis in a way that is affordable, reliable and accessible to everyone. With fast and accurate results in a few minutes, our SARS-CoV-2 viral antigen detection test will give infected patients the information they need to get care quickly and limit the amount of time they unknowingly spread the virus to others. Unlike all other commercialized POC diagnostic tests using inconvenient nasal swab, we will use saliva as a promising sample for facilitating testing due to the ease, safety, and non-invasive nature of its collection. Our novel POC diagnostic test which pairs with our mobile app, allowing people who test negative to get a temporary digital health pass and people who test positive to get tracked to prevent spreading the virus and follow-up their treatment. This integration also enables institutions to derive data insights to monitor patients’ infection status in real-time as well as providing very useful information for decision makers to change the policies regarding controlling the spread of virus during the second wave of pandemic.